SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Centocor ( CNTO )
CNTO 0.000010000.0%Mar 7 3:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: PawPr who wrote (512)1/22/1998 9:25:00 PM
From: FNS   of 965
 
Correct on both counts, Bruce. CYPB is a spinoff from Imre. I understand that CYPB is looking for approval in '98 and revenue in '99. In view of potential RA drugs from both IMNX and CNTO it seems that this procedure might not be cost efective or effective as a drug medication. Perhaps they willlhave a niche market...don't know!

If it were a threat, I'm sure the analysts would have jumped on it!

Glad to see ML upgrading CNTO...now if Holveck comes through shortly we may be able to break out above the 35 3/4 area.

Thanks for your comments.

FNS
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext